Cargando…
Donepezil-associated survival benefits among Alzheimer’s disease patients are retained but not enhanced during COVID-19 infections
BACKGROUND AND AIM: Donepezil is a front-line treatment for Alzheimer’s disease. Donepezil treatment is associated with decreased risk of all-cause mortality. Specific protection is observed in pneumonia and cardiovascular disease. We hypothesized that donepezil treatment would improve mortality amo...
Autores principales: | Edmiston, Elizabeth A., Bej, Taissa A., Wilson, Brigid, Jump, Robin L. P., Phillips, Joy A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10203853/ https://www.ncbi.nlm.nih.gov/pubmed/37234745 http://dx.doi.org/10.1177/20499361231174289 |
Ejemplares similares
-
1088. Evaluating the Effect of Donepezil on Mortality Among Alzheimer’s Disease Patients With and Without COVID-19 Infection
por: Bej, Taissa A, et al.
Publicado: (2022) -
Change to hospitalist providers had a minimal influence on overall antibiotic use in a VA long-term care setting
por: Bej, Taissa, et al.
Publicado: (2023) -
325. Invasive and Non-Invasive Osteomyelitis Caused by Group B Streptococcus Infection Among Veterans
por: Bej, Taissa A, et al.
Publicado: (2020) -
In veteran outpatients, antibiotics remain significant risk factor for community-acquired Clostridiodes difficile infection
por: Akpoji, Ukwen, et al.
Publicado: (2022) -
235. In outpatient clinics serving Veterans, antibiotic prescriptions precede a minority of antibiotic-associated adverse events
por: Wilson, Brigid, et al.
Publicado: (2020)